On the public citation graph
5-Hydroxyindole-2-carboxylic Acid Amides: Novel Histamine-3 Receptor Inverse Agonists for the Treatment of Obesity
0 signed · 110 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.1993.03510180077038openalex-snapshot
Actual Causes of Death in the United States
inferredcites →https://doi.org/10.1001/jama.289.1.76openalex-snapshot
Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001
inferredcites →https://doi.org/10.1001/jama.291.10.1238openalex-snapshot
Actual Causes of Death in the United States, 2000
inferredcites →https://doi.org/10.1002/cmdc.200600179openalex-snapshot
Design, Syntheses, Biological Evaluation, and Docking Studies of 2‐Substituted 5‐Methylsulfonyl‐1‐Phenyl‐1H‐Indoles: Potent and Selective in vitro Cyclooxygenase‐2 Inhibitors
inferredcites →https://doi.org/10.1002/ddr.20140openalex-snapshot
Targeting of the central histaminergic system for treatment of obesity and associated metabolic disorders
inferredcites →https://doi.org/10.1006/phrs.2000.0795openalex-snapshot
Binding affinity profile of betahistine and its metabolites for central histamine receptors of rodents
inferredcites →https://doi.org/10.1007/bf00401402openalex-snapshot
Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse
inferredcites →https://doi.org/10.1007/s00011-005-0034-0openalex-snapshot
Distinctions and contradistinctions between antiobesity histamine H3 receptor (H3R) antagonists compared to cognition-enhancing H3 receptor antagonists
inferredcites →https://doi.org/10.1007/s00011-005-0035-zopenalex-snapshot
Differences in pharmacological properties of histamine H3 receptor agonists and antagonists revealed at two human H3 receptor isoforms
inferredcites →https://doi.org/10.1007/s00011-007-0622-2openalex-snapshot
Minimization of potential hERG liability in histamine H3 receptor antagonists
inferredcites →https://doi.org/10.1016/0006-2952(83)90339-8openalex-snapshot
Effect of a new potent H2-receptor antagonist 3[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric mucosal histamine-sensitive adenylate cyclase from guinea pig
inferredcites →https://doi.org/10.1016/0223-5234(87)90307-2openalex-snapshot
Progress in medicinal chemistry 24
inferredcites →https://doi.org/10.1016/b978-0-444-88931-7.50001-3openalex-snapshot
Pharmacochemistry Library
inferredcites →https://doi.org/10.1016/j.bcp.2004.05.048openalex-snapshot
Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist
inferredcites →https://doi.org/10.1016/j.bcp.2005.10.033openalex-snapshot
The challenge of drug discovery of a GPCR target: Analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists
inferredcites →https://doi.org/10.1016/j.bcp.2007.01.002openalex-snapshot
The brain H3-receptor as a novel therapeutic target for vigilance and sleep–wake disorders
inferredcites →https://doi.org/10.1016/j.bcp.2007.01.034openalex-snapshot
Antagonistic targeting of the histamine H3 receptor decreases caloric intake in higher mammalian species
inferredcites →https://doi.org/10.1016/j.bmc.2008.04.028openalex-snapshot
Support vector machines classification of hERG liabilities based on atom types
inferredcites →https://doi.org/10.1016/j.bmcl.2006.12.061openalex-snapshot
A quantitative assessment of hERG liability as a function of lipophilicity
inferredcites →https://doi.org/10.1016/j.bmcl.2007.04.056openalex-snapshot
A new class of histamine H3 receptor antagonists derived from ligand based design
inferredcites →https://doi.org/10.1016/j.bmcl.2008.06.062openalex-snapshot
Refinement of histamine H3 ligands pharmacophore model leads to a new class of potent and selective naphthalene inverse agonists
inferredcites →https://doi.org/10.1016/j.bmcl.2009.03.100openalex-snapshot
Selective naphthalene H3 receptor inverse agonists with reduced potential to induce phospholipidosis and their quinoline analogs
inferredcites →https://doi.org/10.1016/j.ejphar.2004.01.015openalex-snapshot
Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist
inferredcites →https://doi.org/10.1016/j.ejphar.2008.10.026openalex-snapshot
Cloning and characterization of the monkey histamine H3 receptor isoforms
inferredcites →https://doi.org/10.1016/j.phrs.2008.01.009openalex-snapshot
The hERG K+ channel: target and antitarget strategies in drug development
inferredcites →https://doi.org/10.1016/j.tips.2004.10.003openalex-snapshot
The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders
inferredcites →https://doi.org/10.1016/j.tips.2005.07.002openalex-snapshot
The histamine H receptor as a new therapeutic target for inflammation
inferredcites →https://doi.org/10.1016/s0022-3565(24)29209-0openalex-snapshot
Constitutive Activity of Histamine H3 Receptors Stably Expressed in SK-N-MC Cells: Display of Agonism and Inverse Agonism by H3 Antagonists
inferredcites →https://doi.org/10.1016/s0022-3565(24)37840-1openalex-snapshot
Neurochemical and Behavioral Effects of Ciproxifan, A Potent Histamine H3-Receptor Antagonist
inferredcites →https://doi.org/10.1016/s0026-895x(24)12229-8openalex-snapshot
Genomics Meets Histamine Receptors: New Subtypes, New Receptors
inferredcites →https://doi.org/10.1016/s0031-6997(24)01328-0openalex-snapshot
International Union of Pharmacology. XIII. Classification of Histamine Receptors
inferredcites →https://doi.org/10.1016/s0079-6468(08)70096-1openalex-snapshot
6 The Histamine H3 Receptor and its Ligands
inferredcites →https://doi.org/10.1016/s0091-3057(02)00745-1openalex-snapshot
Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia model
inferredcites →https://doi.org/10.1016/s0140-6736(07)60033-6openalex-snapshot
Drug treatments for obesity: orlistat, sibutramine, and rimonabant
inferredcites →https://doi.org/10.1016/s0165-6147(98)01201-2openalex-snapshot
Therapeutic potential of histamine H3 receptor agonists and antagonists
inferredcites →https://doi.org/10.1016/s0165-7208(98)x8001-3openalex-snapshot
The Histamine H3 Receptor - A Target for New Drugs
inferredcites →https://doi.org/10.1016/s0960-894x(01)00090-7openalex-snapshot
Different antagonist binding properties of human and rat histamine H3 receptors
inferredcites →https://doi.org/10.1016/s1081-1206(10)63041-4openalex-snapshot
Efficacy and Safety of Fexofenadine Hydrochloride for Treatment of Seasonal Allergic Rhinitis
inferredcites →https://doi.org/10.1016/s1359-6446(05)03625-1openalex-snapshot
Keynote review: Histamine H3 receptor antagonists reach out for the clinic
inferredcites →https://doi.org/10.1021/ja00989a045openalex-snapshot
Chemical conversion of tyrosine to 6-hydroxyindoles
inferredcites →https://doi.org/10.1021/jm031028zopenalex-snapshot
1-Alkyl-4-acylpiperazines as a New Class of Imidazole-Free Histamine H3 Receptor Antagonists
inferredcites →https://doi.org/10.1021/jm0341047openalex-snapshot
The First Potent and Selective Non-Imidazole Human Histamine H4Receptor Antagonists
inferredcites →https://doi.org/10.1021/jm040118gopenalex-snapshot
4-(2-[2-(2(R)-Methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and Related 2-Aminoethylbenzofuran H3 Receptor Antagonists Potently Enhance Cognition and Attention
inferredcites →https://doi.org/10.1021/jm051008sopenalex-snapshot
Characterization of the Histamine H4Receptor Binding Site. Part 1. Synthesis and Pharmacological Evaluation of Dibenzodiazepine Derivatives
inferredcites →https://doi.org/10.1021/jm060500oopenalex-snapshot
Common Pharmacophores for Uncharged Human Ether-a-go-go-Related Gene (hERG) Blockers
inferredcites →https://doi.org/10.1021/jm060880dopenalex-snapshot
Discovery of S-(2-Guanidylethyl)-isothiourea (VUF 8430) as a Potent Nonimidazole Histamine H4 Receptor Agonist
inferredcites →https://doi.org/10.1021/jm970530eopenalex-snapshot
Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes
inferredcites →https://doi.org/10.1021/jm980521lopenalex-snapshot
Pharmacological Treatment of Obesity: Therapeutic Strategies
inferredcites →https://doi.org/10.1021/jo01132a001openalex-snapshot
SYNTHESIS AND REACTIONS OF INDOLE CARBOXYLIC ACIDS; PYRIDINDOLONES FROM INDOLE-2-CARBOXYACETALYLBENZYLAMIDES
inferredcites →https://doi.org/10.1021/tx00042a005openalex-snapshot
Mechanistic Studies on the Monoamine Oxidase B Catalyzed Oxidation of 1,4-Disubstituted Tetrahydropyridines
inferredcites →https://doi.org/10.1038/302832a0openalex-snapshot
Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor
inferredcites →https://doi.org/10.1038/bjp.2008.147openalex-snapshot
The histamine H3receptor: an attractive target for the treatment of cognitive disorders
inferredcites →https://doi.org/10.1038/sj.bjp.0705964openalex-snapshot
Acute wake‐promoting actions of JNJ‐5207852, a novel, diamine‐based H3 antagonist
inferredcites →https://doi.org/10.1038/sj.ijo.0803036openalex-snapshot
Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight
inferredcites →https://doi.org/10.1039/b202666jopenalex-snapshot
N–H Insertion reactions of rhodium carbenoids. Part 3.1 The development of a modified Bischler indole synthesis and a new protecting-group strategy for indoles
inferredcites →https://doi.org/10.1093/jn/124.7.1029openalex-snapshot
Manipulation of Central Nervous System Histamine or Histaminergic Receptors (H1) Affects Food Intake in Rats
inferredcites →https://doi.org/10.1111/j.1742-7843.2004.950307.xopenalex-snapshot
In vitro Optimization of Structure Activity Relationships of Analogues of A‐331440 Combining Radioligand Receptor Binding Assays and Micronucleus Assays of Potential Antiobesity Histamine H3 Receptor Antagonists
inferredcites →https://doi.org/10.1124/jpet.104.078303openalex-snapshot
Pharmacological Properties of ABT-239 [4-(2-{2-[(2 R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and Selective Histamine H3 Receptor Antagonist with Drug-Like Properties
inferredcites →https://doi.org/10.1124/jpet.104.078402openalex-snapshot
Pharmacological Properties of ABT-239 [4-(2-{2-[(2 R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist
inferredcites →https://doi.org/10.1124/jpet.106.111039openalex-snapshot
BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H3 Receptor: Preclinical Pharmacology
inferredcites →https://doi.org/10.1124/jpet.107.120311openalex-snapshot
GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer’s Disease Brain and Improves Cognitive Performance in Preclinical Models
inferredcites →https://doi.org/10.1124/mi.6.2.5openalex-snapshot
Histamine H3 Receptor Antagonists: Preclinical Promise for Treating Obesity and Cognitive Disorders
inferredcites →https://doi.org/10.1124/mol.105.019299openalex-snapshot
Discovery of Naturally Occurring Splice Variants of the Rat Histamine H3 Receptor That Act as Dominant-Negative Isoforms
inferredcites →https://doi.org/10.1124/mol.55.6.1101openalex-snapshot
Cloning and Functional Expression of the Human Histamine H3Receptor
inferredcites →https://doi.org/10.1124/mol.59.3.420openalex-snapshot
Cloning and Pharmacological Characterization of a Fourth Histamine Receptor (H4) Expressed in Bone Marrow
inferredcites →https://doi.org/10.1159/000063794openalex-snapshot
Coordination of Histamine H3 Receptor Antagonists with Human Adrenal Cytochrome P450 Enzymes
inferredcites →https://doi.org/10.1248/bpb.31.2163openalex-snapshot
Histamine H3 Receptor Antagonists Go to Clinics
inferredcites →https://doi.org/10.1517/13543784.14.3.223openalex-snapshot
Assessment of pharmacology and potential anti-obesity properties of H3receptor antagonists/inverse agonists
inferredcites →https://doi.org/10.2165/00003495-199957060-00005openalex-snapshot
Current Concepts in the Pharmacological Management of Obesity
inferredcites →https://doi.org/10.2174/092986706776872880openalex-snapshot
Antiobesity Therapy: Emerging Drugs and Targets
inferredcites →https://doi.org/10.2174/187152707779940790openalex-snapshot
Histaminergic Control of Sleep-Wake Cycles: Recent Therapeutic Advances for Sleep and Wake Disorders
inferredcites →https://doi.org/10.2533/chimia.2000.640openalex-snapshot
CAFCA: a Novel Tool for the Calculation of Amphiphilic Properties of Charged Drug Molecules
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/0471264180.or092.02openalex-snapshot
Cyclization of Vinyl and Aryl Azides into Pyrroles, Indoles, Carbazoles, and Related Fused Pyrroles
inferred← citeshttps://doi.org/10.1002/adsc.201200162openalex-snapshot
Copper‐Catalyzed Activation of Dioxygen: Oxidative Cyclization of 2‐Arylindoles
inferred← citeshttps://doi.org/10.1002/ardp.200900307openalex-snapshot
Difluorotetrahydropyridothiazinone: A Selective β‐Galactosidase Inhibitor
inferred← citeshttps://doi.org/10.1002/jbt.20375openalex-snapshot
Gene expression‐based in vivo and in vitro prediction of liver toxicity allows compound selection at an early stage of drug development
inferred← citeshttps://doi.org/10.1002/slct.201701902openalex-snapshot
Synthesis and Biological Evaluation of (N‐(3‐methoxyphenyl)‐4‐((aryl‐1 H ‐1,2,3‐triazol‐4‐yl)methyl)thiomorpholine‐2‐carboxamide 1,1‐Dioxide Hybrids as Antiproliferative Agents
inferred← citeshttps://doi.org/10.1007/978-3-319-04346-3_1openalex-snapshot
Tactical Applications of Fluorine in Drug Design and Development
inferred← citeshttps://doi.org/10.1007/978-3-319-40308-3_5openalex-snapshot
Histamine H3R Antagonists: From Scaffold Hopping to Clinical Candidates
inferred← citeshttps://doi.org/10.1007/s00253-009-2207-1openalex-snapshot
Regioselective oxidation of indole- and quinolinecarboxylic acids by cytochrome P450 CYP199A2
inferred← citeshttps://doi.org/10.1016/j.bcp.2019.07.006openalex-snapshot
KSK19 – Novel histamine H3 receptor ligand reduces body weight in diet induced obese mice
inferred← citeshttps://doi.org/10.1016/j.bmc.2020.115307openalex-snapshot
Development of a potent and orally active activator of adenosine monophosphate-activated protein kinase (AMPK), ASP4132, as a clinical candidate for the treatment of human cancer
inferred← citeshttps://doi.org/10.1016/j.bmc.2021.116437openalex-snapshot
Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmcl.2010.08.009openalex-snapshot
Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold
inferred← citeshttps://doi.org/10.1016/j.bmcl.2010.08.103openalex-snapshot
Indole- and benzothiophene-based histamine H3 antagonists
inferred← citeshttps://doi.org/10.1016/j.ejmech.2017.10.034openalex-snapshot
Novel indole and triazole based hybrid molecules exhibit potent anti-adipogenic and antidyslipidemic activity by activating Wnt3a/β-catenin pathway
inferred← citeshttps://doi.org/10.1016/j.fbio.2024.103825openalex-snapshot
Biological Transformation of Medicine and Food Homology Hawthorn with Monascus Ruber to Enhance Lipid-Lowering Function
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2015.07.002openalex-snapshot
The histaminergic system as a target for the prevention of obesity and metabolic syndrome
inferred← citeshttps://doi.org/10.1016/j.phrs.2025.107949openalex-snapshot
Brain histaminergic system: An emerging target for the treatment of feeding and eating-related disorders
inferred← citeshttps://doi.org/10.1016/j.saa.2011.12.048openalex-snapshot
DFT, FT-Raman and FT-IR investigations of 1-cyclobutylpiperazine
inferred← citeshttps://doi.org/10.1016/j.tet.2015.08.035openalex-snapshot
5-Hydroxybenzo[g]indoles formation from oxa-aza[3.3.3]propellanes
inferred← citeshttps://doi.org/10.1021/acs.chemrev.6b00274openalex-snapshot
Oxetanes: Recent Advances in Synthesis, Reactivity, and Medicinal Chemistry
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.7b00523openalex-snapshot
Discovery and Optimization of Chromeno[2,3- c ]pyrrol-9(2 H )-ones as Novel Selective and Orally Bioavailable Phosphodiesterase 5 Inhibitors for the Treatment of Pulmonary Arterial Hypertension
inferred← citeshttps://doi.org/10.1021/acs.joc.7b01136openalex-snapshot
Catalyst-free Synthesis of 6-Hydroxy Indoles via the Condensation of Carboxymethyl Cyclohexadienones and Amines
inferred← citeshttps://doi.org/10.1021/jm100064dopenalex-snapshot
Histamine H3Receptor as a Drug Discovery Target
inferred← citeshttps://doi.org/10.1021/jm201697vopenalex-snapshot
Indole-Based Fibrates as Potential Hypolipidemic and Antiobesity Agents
inferred← citeshttps://doi.org/10.1021/jm300343mopenalex-snapshot
Mitigating Heterocycle Metabolism in Drug Discovery
inferred← citeshttps://doi.org/10.1021/jm301097popenalex-snapshot
Identification of Small-Molecule Enhancers of Arginine Methylation Catalyzed by Coactivator-Associated Arginine Methyltransferase 1
inferred← citeshttps://doi.org/10.1039/c1md00002kopenalex-snapshot
N-(5-substituted thiazol-2-yl)-2-aryl-3-(tetrahydro-2H-pyran-4-yl) propanamides as glucokinase activators
inferred← citeshttps://doi.org/10.1080/14756366.2018.1509212openalex-snapshot
Design, synthesis, and biological evaluation of novel iso-flavones derivatives as H3R antagonists
inferred← citeshttps://doi.org/10.1517/13543776.2010.509346openalex-snapshot
Recent advances in histamine H3receptor antagonists/inverse agonists
inferred← citeshttps://doi.org/10.1517/17460440903264972openalex-snapshot
Molecular modeling and QSAR-based design of histamine receptor ligands
inferred← citeshttps://doi.org/10.2147/nsa.s445116openalex-snapshot
Antihistamine and Wound Healing Potential of Gold Nanoparticles Synthesized Using Bulbine frutescens (L.) Willd
inferred← citeshttps://doi.org/10.2174/1570159x21666221117153755openalex-snapshot
The Diverse Network of Brain Histamine in Feeding: Dissect its Functions in a Circuit-Specific Way
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.